Methylprednisolone induced liver injury in a patient with multiple sclerosis

Authors

  • Tamara Milovanovic Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade; School of Medicine, University of Belgrade, Belgrade, Serbia
  • Katarina Jankovic Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia
  • Ivan Boricic School of Medicine, University of Belgrade, Belgrade; Institute of Pathology, School of Medicine, University of Belgrade, Belgrade, Serbia
  • Sanja Dragasevic Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade; School of Medicine, University of Belgrade, Belgrade, Serbia
  • Milica Stojkovic Lalosevic Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade; School of Medicine, University of Belgrade, Belgrade, Serbia
  • Igor Dumic Mayo Clinic, College of Medicine, Rochester, MN, USA

DOI:

https://doi.org/10.15403/jgld-686

Keywords:

Methylprednisolone, multiple sclerosis, liver injury

Downloads

Published

2020-03-13

How to Cite

1.
Milovanovic T, Jankovic K, Boricic I, Dragasevic S, Stojkovic Lalosevic M, Dumic I. Methylprednisolone induced liver injury in a patient with multiple sclerosis. JGLD [Internet]. 2020 Mar. 13 [cited 2026 Mar. 12];29(1):119-20. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/686

Issue

Vol. 29 No. 1: March 2020

Section

Letters